Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 41.

Aigner, F; Husmann, M; Huber, L C; Benden, C; Schuurmans, M M (2017). Conservative management of distal leg necrosis in lung transplant recipients. Journal of Tissue Viability, 26(2):95-102.

Huber, L C; Bye, H; Brock, M (2015). The pathogenesis of pulmonary hypertension - an update. Swiss Medical Weekly:145.

Murer, C; Bürgi, U; Kohler, M; Benden, C; Huber, L C (2015). Adenocarcinoma of the gastrointestinal tract in lung transplanted patients with cystic fibrosis: case series and review of the literature. Swiss Medical Weekly:145.

Henzi, N; Vrugt, B; Schneiter, D; Studt, J D; Huber, L C (2015). Pulmonales Panoptikum nach Lungenbiopsie. Swiss Medical Forum:958-961.

Darwiche, K; Ozkan, F; Ting, S; Johnen, G; Brüning, T; Soltermann, A; Huber, L C; Christoph, D C; Freitag, L; Franzen, D (2014). Prätherapeutische Biomarker des Lungenkarzinoms unter besonderer Berücksichtigung der Bronchoskopie. Pneumologie (Stuttgart, Germany), 68(11):719-726.

Huber, L C; Bürgi, U; Schuurmans, M M; Benden, C (2014). Non-CF-Bronchiektasen: Diagnostik und Therapie. Deutsche Medizinische Wochenschrift, 139(34-35):1714-1720.

Huber, L C; Leuenberger, C; Kohler, M; Brock, M (2014). Pulmonale Hypertonie: mikroRNAs in Pathogenese, Diagnostik und Therapie. Pneumologie (Stuttgart, Germany), 68(6):386-393.

Brock, M; Samillan, V J; Trenkmann, M; Schwarzwald, C C; Ulrich, S; Gay, R E; Gassmann, M; Ostergaard, L; Gay, S; Speich, R; Huber, L C (2014). AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension. European Heart Journal, 35(45):3203-3211.

Huber, L C; Wieser, S (2013). Reexpansionslungenoedem. Swiss Medical Forum, 13(17):349-350.

Brockmann, M; Huber, L C (2013). Vascular remodeling in Hypoxia- induced pulmonary hypertension: Role of Cytokines and MicroRNAs. PVRI Review, 5(1):20-23.

Huber, L C. Vascular remodeling in pulmonary hypertension. 2013, University of Zurich, Faculty of Medicine.

Glutz von Blotzheim, L; Müller, N J; Huber, L C; Degen, T (2012). 76-jährige Patientin mit tiefer Beinvenenthrombose und zervikaler Lymphadenopathie. Der Internist, 53(6):756-759.

Trenkmann, M; Brock, M; Gay, R E; Kolling, C; Speich, R; Michel, B A; Gay, S; Huber, L C (2011). Expression and function of EZH2 in synovial fibroblasts: epigenetic repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Annals of the Rheumatic Diseases, 70(8):1482-1488.

Brock, M; Trenkmann, M; Gay, R E; Gay, S; Speich, R; Huber, L C (2011). MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. Journal of Biological Chemistry, 286(46):40142-40150.

Ulrich, S; Huber, L C; Fischler, M; Treder, U; Maggiorini, M; Eberli, F R; Speich, R (2011). Platelet serotonin content and transpulmonary platelet serotonin gradient in patients with pulmonary hypertension. Respiration, 81(3):211-216.

Hochhegger, B; Irion, K; Roach, P J; Müller, V; Huber, L C (2010). Acute pulmonary embolism. New England Journal of Medicine, 363(20):1972-author reply 1974.

Ospelt, C; Mertens, J C; Jüngel, A; Brentano, F; Maciejewska Rodrigues, H; Huber, L C; Hemmatazad, H; Wüest, T; Knuth, A; Gay, R E; Michel, B A; Gay, S; Renner, C; Bauer, S (2010). Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis and Rheumatism, 62(5):1224-1235.

Ulrich, S; Szamalek-Hoegel, J; Hersberger, M; Fischler, M; Solera Garcia, J; Huber, L C; Grünig, E; Janssen, B; Speich, R (2010). Sequence variants in BMPR2 and genes involved in the serotonin and nitric oxide pathways in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: relation to clinical parameters and comparison with left heart disease. Respiration, 79(4):279-287.

Huber, L C; Kamarachev, J; Maggiorini, M; Müller, V (2010). Skin rash in a patient with A(H1N1) infection. Intensive Care Medicine, 36(10):1793-1794.

Schiess, R; Senn, O; Fischler, M; Huber, L C; Vatandaslar, S; Speich, R; Ulrich, S (2010). Tobacco smoke: a risk factor for pulmonary arterial hypertension? A case control study. Chest, 138(5):1086-1092.

Huber, L C; Wüthrich, R P; Gloor, H J (2010). Wie lautet Ihre Diagnose? Nephrologie. Praxis, 99(17):1011-1013.

Brock, M; Trenkmann, M; Gay, R E; Michel, B A; Gay, S; Fischler, M; Ulrich, S; Speich, R; Huber, L C (2009). Interleukin-6 Modulates the Expression of the Bone Morphogenic Protein Receptor Type II Through a Novel STAT3-microRNA Cluster 17/92 Pathway. Circulation Research, 104(10):1184-11191.

Hemmatazad, H; Maciejewska Rodrigues, H; Maurer, B; Brentano, F; Pileckyte, M; Distler, J H W; Gay, R E; Michel, B A; Gay, S; Huber, L C; Distler, O; Jüngel, A (2009). Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis. Arthritis and Rheumatism, 60(5):1519-1529.

Ulrich, S; Hersberger, M; Fischler, M; Huber, L C; Senn, O; Treder, U; Speich, R; Schmid, C (2009). Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension. Open Respiratory Medicine Journal, 3:53-60.

Huber, L C; Soltermann, A; Fischler, M; Gay, S; Weder, W; Russi, E W; Speich, R; Ulrich, S (2009). Caveolin-1 Expression and Hemodynamics in COPD Patients. Open Respiratory Medicine Journal, 3:73-78.

Frei, P; Huber, L C; Simon, R W; Bonani, M; Lüscher, T F (2009). Insufficient medication documentation at hospital admission of cardiac patients: a challenge for medication reconciliation. Journal of Cardiovascular Pharmacology, 54(6):497-501.

Huber, L C; Jüngel, A; Gay, S (2009). Targeting the epigenetic modifications of synovial cells. In: Tak, P P. New Therapeutic Targets in Rheumatoid Arthritis. Basel, Switzerland: Birkhauser / Springer, 193-206.

Ulrich, S; Taraseviciene-Stewart, L; Huber, L C; Speich, R; Voelkel, N (2008). Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study. Respiratory Research, 9:20.

Huber, L C; Künzler, P; Boyce, S H; Michel, B A; Gay, R E; Ink, B S; Gay, S (2008). Effects of a novel tyrosine kinase inhibitor in rheumatoid arthritis synovial fibroblasts. Annals of the Rheumatic Diseases, 67(3):389-394.

Huber, L C; Mueller, N J; Schanz, U; Irani, S; Stüssi, G; Zbinden, R; Fischler, M (2008). Gartenarbeit mit Folgen. Swiss Medical Forum, 8(47):924-925.

Drees, P; Eckardt, A; Gay, R E; Gay, S; Huber, L C (2008). Molekulare Signalwege der aseptischen Endoprothesenlockerung (Molecular pathways in aseptic loosening of orthopaedic endoprosthesis). Biomedizinische Technik. Biomedical Engineering, 53(3):93-103.

Spring, R M; Ulrich, S; Huber, L C; Speich, R; Maggiorini, M; Treder, U; Fischler, M (2008). Sildenafil for pulmonary hypertension: dose-dependent improvement in exercise performance. Pulmonary Pharmacology and Therapeutics, 21(3):516-521.

Guiducci, S; Distler, J H W; Jüngel, A; Huscher, D; Huber, L C; Michel, B A; Gay, R E; Pisetsky, D S; Gay, S; Matucci-Cerinic, M; Distler, O (2008). The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis and Rheumatism, 58(9):2845-2853.

Huber, L C; Distler, J H W; Moritz, F; Hemmatazad, H; Hauser, T; Michel, B A; Gay, R E; Matucci-Cerinic, M; Gay, S; Distler, O; Jüngel, A (2007). Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis. Arthritis and Rheumatism, 56(8):275-264.

Huber, L C; Jüngel, A; Distler, J H W; Moritz, F; Gay, R E; Michel, B A; Pisetsky, D S; Gay, S; Distler, O (2007). The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Apoptosis, 12(2):363-374.

Distler, J H W; Jüngel, A; Huber, L C; Schulze-Horsel, U; Zwerina, J; Gay, R E; Michel, B A; Hauser, T; Schett, G; Gay, S; Distler, O (2007). Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis and Rheumatism, 56(1):311-322.

Huber, L C; Moritz, F; Gay, S (2007). Spondylarthritides and related entities: entheses and hypotheses. Arthritis and Rheumatism, 56(1):4-8.

Huber, L C; Distler, O; Tarner, I; Gay, R E; Gay, S; Pap, T (2006). Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology, 45(6):669-675.

Huber, L C; Gay, S; Distler, O; Pisetsky, D S (2006). The effect of UVB on lupus skin: new light on the role of apoptosis in the pathogenesis of autoimmunity. Rheumatology, 45(5):500-501.

Huber, L C; Distler, O; Gay, R E; Gay, S (2006). Antisense strategies in degenerative joint diseases: sense or nonsense? Advanced Drug Delivery Reviews, 58(2):285-299.

Distler, J H W; Jüngel, A; Huber, L C; Seemayer, C A; Reich, C F; Gay, R E; Michel, B A; Fontana, A; Gay, S; Pisetsky, D S; Distler, O (2005). The induction of matrix metalloproteinase and cytokine expression in synovial fibroblasts stimulated with immune cell microparticles. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 102(8):2892-2897.

This list was generated on Tue Jun 18 01:12:21 2019 CEST.